Literature DB >> 9376993

Quantitative assessment of salivary gland inflammatory infiltration in primary Sjögren's syndrome: its relationship to different demographic, clinical and serological features of the disorder.

R Gerli1, C Muscat, M Giansanti, M G Danieli, M Sciuto, A Gabrielli, E Fiandra, C Vitali.   

Abstract

The aim of this study was to investigate the possible relationship between the degree of inflammatory infiltration of salivary glands in Sjögren's syndrome (SS) and the different demographic, clinical and serological features of the disease. A quantitative assessment of the extension of the infiltrates was performed on histology samples from the labial salivary glands (LSG) of 82 patients with primary SS, by calculating the ratio of the infiltrated area to the total area of glandular tissue in the samples. The correlations between the amount of inflammatory infiltrate and the main features of the disorder were then analysed. A significant negative correlation between the degree of LSG infiltration and the patient's age at disease onset was observed (P < 0.05). In contrast, the percentage of infiltrate did not correlate with the disease duration. A significant correlation was found between the degree of infiltration of the salivary tissue and (i) the total number of extraglandular features (P < 0.01) and (ii) the presence of specific extraglandular features such as Raynaud's phenomenon (P < 0.05), vasculitis (P < 0.0001), lymph node or spleen enlargement (P < 0.05) and leucopenia (P < 0.02). Finally, patients with antinuclear antibodies, anti-SSA/Ro antibodies, or anti-SSA/Ro plus anti-SSB/La antibodies showed a more widespread inflammatory infiltration in the LSG tissue than patients without these autoantibodies (P < 0.01). The degree of infiltration in the salivary tissue was significantly greater in those patients with anti-SSA/Ro plus anti-SSB/La antibodies in their sera than in patients with anti-SSA/Ro antibodies alone (P < 0.05). In conclusion, patients with SS and active inflammatory infiltration of the salivary glands usually experience an earlier disease onset and a larger number of systemic extraglandular manifestations. In addition, the antibodies directed against certain nuclear/cytoplasmic specificities, and particularly those which react with the SSB/La antigen, seem to play a key role in enhancing the autoimmune process in the salivary glands.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9376993     DOI: 10.1093/rheumatology/36.9.969

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  17 in total

1.  Correlations between histopathologic and scintigraphic parameters of salivary glands in patients with Sjögren's syndrome.

Authors:  Tamer Aksoy; Pinar Ozgen Kiratli; Belkis Erbas
Journal:  Clin Rheumatol       Date:  2012-06-26       Impact factor: 2.980

2.  Biomarkers. Saliva proteomics is a promising tool to study Sjögren syndrome.

Authors:  Athanasios G Tzioufas; Efstathia K Kapsogeorgou
Journal:  Nat Rev Rheumatol       Date:  2015-02-10       Impact factor: 20.543

Review 3.  Primary Sjögren's syndrome: clinical phenotypes, outcome and the development of biomarkers.

Authors:  Andreas V Goules; Athanasios G Tzioufas
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

4.  Focal sialadenitis in patients with ankylosing spondylitis and spondyloarthropathy: a comparison with patients with rheumatoid arthritis or mixed connective tissue disease.

Authors:  L M Helenius; J H Hietanen; I Helenius; H Kautiainen; H Piirainen; L Paimela; M Lappalainen; R Suuronen; C Lindqvist; M Leirisalo-Repo
Journal:  Ann Rheum Dis       Date:  2001-08       Impact factor: 19.103

5.  Sjögren's syndrome in the community: can serology replace salivary gland biopsy?

Authors:  Aharon Kessel; Elias Toubi; Michael Rozenbaum; Devy Zisman; Edmond Sabo; Itzhak Rosner
Journal:  Rheumatol Int       Date:  2005-02-10       Impact factor: 2.631

6.  Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors.

Authors:  Maria I Christodoulou; Efstathia K Kapsogeorgou; Niki M Moutsopoulos; Haralampos M Moutsopoulos
Journal:  Am J Pathol       Date:  2008-09-25       Impact factor: 4.307

7.  Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjögren's syndrome.

Authors:  E Toker; S Yavuz; H Direskeneli
Journal:  Br J Ophthalmol       Date:  2004-03       Impact factor: 4.638

8.  A case for IL-6, IL-17A, and nitric oxide in the pathophysiology of Sjögren's syndrome.

Authors:  Sarah Benchabane; Abdelhalim Boudjelida; Ryma Toumi; Houda Belguendouz; Pierre Youinou; Chafia Touil-Boukoffa
Journal:  Int J Immunopathol Pharmacol       Date:  2016-05-19       Impact factor: 3.219

9.  Interferon gamma-inducible protein 16 in primary Sjögren's syndrome: a novel player in disease pathogenesis?

Authors:  Alessia Alunno; Valeria Caneparo; Francesco Carubbi; Onelia Bistoni; Sara Caterbi; Elena Bartoloni; Roberto Giacomelli; Marisa Gariglio; Santo Landolfo; Roberto Gerli
Journal:  Arthritis Res Ther       Date:  2015-08-14       Impact factor: 5.156

10.  Sialometry of upper labial minor glands: a clinical approach by the use of weighing method Schirmer's test strips paper.

Authors:  Denise Pinheiro Falcão; Soraya Coelho Leal; Celi Novaes Vieira; Andy Wolff; Tayana Filgueira Galdino Almeida; Fernanda de Paula e Silva Nunes; Rivadávio Fernandes Batista de Amorim; Ana Cristina Bezerra
Journal:  ScientificWorldJournal       Date:  2014-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.